Vinegar is shown to reduce fasting glucose levels among patients at risk for type 2 diabetes… 

In contrast to findings from previous studies, the development of breast cancer is not tied to insulin use, a new study says… 

Pancreas transplant alone (PTA) may be a viable option for fragile individuals with uncontrolled diabetes due to its promising outcomes…. 

GDM risk for obese and overweight women with low adiponectin even higher….

Dr. Szilard Voros, MD, is part of a team at Health Diagnostic Laboratory, who have developed a unique new panel of tests for diabetes. He tells us a little about himself and why he is so passionate about cardiology and the connection to diabetes. Other videos with Dr. Voros: New Panel …

Szilard Voros, MD, FACC, FSCCT, FAHA, talks about how new panels of test he and his team at Health Diagnostic Laboratory have created can catch diseases earlier. The new Diabetes Prevention & Management Panel (DPMP) grew out of the recognition that up to 70% of the CV patients that the team had been …

Szilard Voros, MD, FACC, FSCCT, FAHA, talks about how beta cell resistance can start in the normal range of A1c tests, and a study that his team at Health Diagnostic Laboratory did looking at ADA classification. Using newer biomarkers, they were able to uncover 28% more patients as prediabetic than with …

  Szilard Voros, MD, FACC, FSCCT, FAHA, discusses the fact that current tests for diabetes can be remarkably inaccurate, including the A1c test. Even in the “normal” A1c range for non-diabetics, there can still be considerable risk of impaired glucose tolerance in the post-prandial state….

Szilard Voros, MD, FACC, FSCCT, FAHA, talks about the biomarkers that he and his team at Health Diagnostic Laboratory have identified for beta cell dysfunction including insulin precursors. He believes that the proinsulin to c-peptide ratio in the fasting state is the best marker of beta-cell strain they have found so far. …

Szilard Voros, MD, FACC, FSCCT, FAHA, explains that the new Diabetes Prevention & Management Panel test from Health Diagnostic Laboratory is comprehensive enough to easily identify not only whether a patient is type 1 or 2 but also 1.5, and other diabetes variants….